EGFR and neoplasm: As expected, non‐targeted and EGFR‐targeted immRNA‐loaded RBCEVs suppressed the engraftment of metastatic tumour cells as shown by the decreased percentage of hEGFR‐positive cells in the lungs (Figures 7b‐c and S7A).